Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal

European Journal of Pharmacology

Volumn 387, Issue 1, 2000, Pages 47-53

  Beardsley, Patrick M ^a   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Rat); Behavioral dependence; Dependence; Operant behavior; SR141716A; THC (tetrahydrocannabinol); Withdrawal

Indexed keywords

CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RATS, LONG-EVANS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

EID: 0033982914     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00792-X     Document Type: Article

References (31)

1. Aceto M.D. Assessment of physical dependence techniques for the evaluation of abused drugs. Adler M.W., Cowan A. Testing and Evaluation of Drugs of Abuse. 1990;67-79 Wiley-Liss, New York.
2. Aceto M., Scates S., Lowe J., Martin B. Cannabinoid precipitated withdrawal by selective cannabinoid antagonist, SR141716A. Eur. J. Pharmacol. 282:1995;R1-R2.
3. 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J. Pharmacol. Exp. Ther. 278:1996;1290-1295.
4. Beardsley P.M., Balster R.L. Behavioral dependence upon phencyclidine and ketamine in the rat. J. Pharmacol. Exp. Ther. 242:1987;203-211.
5. Beardsley P.M., Balster R.L., Harris L.S. Dependence on tetrahydrocannabinol in rhesus monkeys. J. Pharmacol. Exp. Ther. 239:1986;311-319.
6. Carroll M.E., Lac S.T., Asencio M., Keenan R.M. Nicotine dependence in rats. Life Sci. 45:1989;1381-1388.
7. Compton D.R., Dewey W.L., Martin B.R. Cannabis dependence and tolerance production. Adv. Alcohol Subst. Abuse. 9:1990;129-147.
8. Compton D.R., Aceto M.D., Lowe J., Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277:1996;586-594.
9. Deneau G.A., Kaymakcalan S. Physiological and psychological dependence to synthetic delta-9-tetrahydrocannabinol (THC) in rhesus monkeys. Pharmacologist. 13:1971;246.
10. 9-tetrahydrocannabinol on behavior and the cardiovascular system. Arch. Int. Pharmacodyn. Ther. 198:1972;118-131.
11. Diggle P.J., Liang K.Y., Zeger S.L. Analysis of Longitudinal Data. 1994;253 Clarendon Press, Oxford.
12. Dobson A. An Introduction to Generalized Linear Models. 1990;174 Chapman & Hall, London.
13. 9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacology. 71:1980;201-202.
14. 9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacologia. 37:1974;23-29.
15. Holtzman S.G., Villarreal J.E. Operant behavior in the morphine-dependent rhesus monkey. J. Pharmacol. Exp. Ther. 184:1973;528-541.
16. Jones R.T., Benowitz N. The 30-day trip - clinical studies of cannabis tolerance and dependence. Braude M.C., Szara S. Pharmacology of Marihuana. 2:1976;627-642 Raven Press, New York.
17. Jones R.T., Benowitz N.L., Herning R.I. Clinical relevance of cannabis tolerance and dependence. J. Clin. Pharmacol. 21:1981;143S-152S.
18. Leite J.R., Carlini E.A. Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts. Psychopharmacologia. 36:1974;133-145.
19. Liang K.Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika. 73:1986;13-22.
20. 1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology. 124:1996;315-322.
21. McCullagh P. Quasi-likelihood functions. Ann. Math. Stat. 11:1983;59-67.
22. McCullagh P., Nelder J.A. Generalized Linear Models. 1989;509 Chapman & Hall, London.
23. 9-trans-tetrahydrocannabinol in pigeons: tolerance to the behavioral effects. Science. 169:1970;501-503.
24. Mendelson J.H., Mello N.K., Lex B.W., Bavli S. Marijuana withdrawal syndrome in a woman. Am. J. Psychiatry. 141:1984;1289-1290.
25. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
26. Schuster C.R., Thompson T. Self-administration of and behavioral dependence on drugs. Annu. Rev. Pharmacol. 9:1969;483-502.
27. Slifer B.L., Balster R.L., Woolverton W.L. Behavioral dependence produced by continuous phencyclidine infusion in rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;399-406.
28. Stadnicki S.W., Schaeppi U., Rosenkrantz U., Braude M.C. Crude marijuana extract: EEG and behavioral effects of chronic oral administration. Psychopharmacologia. 37:1974;225-233.
29. Thompson T., Schuster C.R. Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia. 5:1964;87-94.
30. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur. J. Pharmacol. 280:1995;R13-R15.
31. Wiesbeck G.A., Schuckit M.A., Kalmijn J.A., Tipp J.E., Bucholz K.K., Smith T.L. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction. 91:1996;1469-1478.